Monthly
US$200
Billed every month
Sign in to subscribeSacubitril Valsartan Sodium Tablets
As of 13 November 2026, for Sacubitril Valsartan Sodium Tablets, 70 applications are listed as under review at China's CDE; 11 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 41 holders.
Companies, stages and changes, with each record available on this page.
Listed in the US FDA Orange Book as ENTRESTO (NDA 207620, NOVARTIS PHARMACEUTICALS CORP).
Last 90 days: Marketing application approved: 2 applicationsAccepted: 11 applicationsNo longer listed under review: 13 applicationsSupplement delivery: 8 applicationsNotification delivery: 5 applications
Current coverage may be incomplete
US Orange Book listing
The brand names come from the US FDA Orange Book and describe US listing records for this active ingredient. They do not indicate that products under these brand names are approved or sold in China, or that Chinese applicants are affiliated with US holders.
Orange Book source export date: 2026/11/06. Version: 2026-11-06.
Showing 2 of 2 distinct brand names.
A brand with different source forms or statuses can appear on multiple rows and in both groups. Distinct brand names are counted once globally, with a limit of five.
Verified official English dosage form: Tablets. Listings are grouped by the source dosage form and route; records without a clear correspondence are listed in the other group. Grouping does not establish product equivalence.
Same dosage form
| Brand name | Applicant (source text) | Application number | Dosage form (source text) | Route (source text) | Marketing status (source text) | Approval date |
|---|---|---|---|---|---|---|
| ENTRESTO | NOVARTIS PHARMACEUTICALS CORP | NDA 207620 · Product no. 001, 002, 003 | TABLET | ORAL | HUMAN PRESCRIPTION DRUG | 2015/07/07 |
Other dosage forms of the same ingredient
| Brand name | Applicant (source text) | Application number | Dosage form (source text) | Route (source text) | Marketing status (source text) | Approval date |
|---|---|---|---|---|---|---|
| ENTRESTO SPRINKLE | NOVARTIS PHARMACEUTICALS CORP | NDA 218591 · Product no. 001, 002 | CAPSULE, PELLETS | ORAL | HUMAN PRESCRIPTION DRUG | 2024/04/12 |
Same-form/route listings come first, followed by other forms/routes. Within each group, source prescription/OTC listings precede discontinued listings; unknown statuses are last. Each status bucket is ordered by earliest approval date, ascending: pre-1982 records first, missing dates last; ties by brand name, application number and product number. The first five distinct brands in this order are selected globally. All retained source facts for those brands are shown in their own groups; a brand spanning both groups counts once.
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders41View records ↓
Under-review filings70View records ↓
This year’s generic filers11View records ↓
NHSA approval numbers75View records ↓
API companies with A status28View records ↓
Chemical-drug catalogue
Loaded records: 41 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 39 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Chengdu Qin Run Pharmaceuticals Technology Co., Ltd. romanized | Name not romanized | 国药准字H20265993 | 2026/09/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shenyang Ao Ji Na Pharma Co., Ltd. romanized | Shenyang Ao Ji Na Pharma Co., Ltd. romanized | 国药准字H20266004 | 2026/09/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shenyang Ao Ji Na Pharma Co., Ltd. romanized | Shenyang Ao Ji Na Pharma Co., Ltd. romanized | 国药准字H20266003 | 2026/09/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Suzhou Zhong Hua Medicines Gong Ye Co., Ltd. romanized | Suzhou Zhong Hua Medicines Gong Ye Co., Ltd. romanized | 国药准字H20266010 | 2026/09/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chengdu Qin Run Pharmaceuticals Technology Co., Ltd. romanized | Name not romanized | 国药准字H20265992 | 2026/09/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Shen Hua Pharma Co., Ltd. romanized | Jiangsu Shen Hua Pharma Co., Ltd. romanized | 国药准字H20265154 | 2026/07/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Zhong Bang Pharmaceutical Co., Ltd. romanized | Jiangsu Zhong Bang Pharmaceutical Co., Ltd. romanized | 国药准字H20264961 | 2026/06/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Zhong Bang Pharmaceutical Co., Ltd. romanized | Jiangsu Zhong Bang Pharmaceutical Co., Ltd. romanized | 国药准字H20264960 | 2026/06/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264914 | 2026/06/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264915 | 2026/06/23 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264565 | 2026/05/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264564 | 2026/05/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264566 | 2026/05/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | Hunan Wei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20263294 | 2026/02/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | Hunan Wei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20263293 | 2026/02/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | 国药准字H20263184 | 2026/01/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | 国药准字H20263183 | 2026/01/20 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangxi Tai Ji Li Biopharmaceuticals Technology Co., Ltd. romanized | Jiu Zhou Biopharmaceuticals (Tai Zhou) Co., Ltd. romanized | 国药准字H20256181 | 2025/12/09 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20258280 | 2025/12/09 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20258258 | 2025/11/21 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20255722 | 2025/10/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20255723 | 2025/10/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20255724 | 2025/10/14 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Li Tai Er Pharma Co., Ltd. romanized | Jiangsu Li Tai Er Pharma Co., Ltd. romanized | 国药准字H20255486 | 2025/09/16 | See source | Not stated by source | CDE |
| Jiangsu Li Tai Er Pharma Co., Ltd. romanized | Jiangsu Li Tai Er Pharma Co., Ltd. romanized | 国药准字H20255485 | 2025/09/16 | See source | Not stated by source | CDE |
| Di Sha Pharma Group Co., Ltd. romanized | Di Sha Pharma Group Co., Ltd. romanized | 国药准字H20255348 | 2025/09/09 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20255148 | 2025/08/19 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20255147 | 2025/08/19 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | Xin Hua Pharmaceutical (Gao Mi) Co., Ltd. romanized | 国药准字H20255131 | 2025/08/19 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Qian Jin Xie Li Pharma Co., Ltd. romanized | Hunan Qian Jin Xie Li Pharma Co., Ltd. romanized | 国药准字H20254868 | 2025/07/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20254533 | 2025/06/10 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20254532 | 2025/06/10 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20254480 | 2025/06/10 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20254481 | 2025/06/10 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20254531 | 2025/06/10 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hunan Qian Jin Xie Li Pharma Co., Ltd. romanized | Hunan Qian Jin Xie Li Pharma Co., Ltd. romanized | 国药准字H20254250 | 2025/05/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Le Pu Pharma Co., Ltd. romanized | Le Pu Pharma Co., Ltd. romanized | 国药准字H20254029 | 2025/04/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jilin Si Huan Pharmaceutical Co., Ltd. romanized | Jilin Si Huan Pharmaceutical Co., Ltd. romanized | 国药准字H20258061 | 2025/04/09 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Mu Bang (Beijing) Pharmaceuticals Technology Co., Ltd. romanized | Hua Run Shuang He Pharma Co., Ltd. romanized | 国药准字H20253791 | 2025/04/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Mu Bang (Beijing) Pharmaceuticals Technology Co., Ltd. romanized | Hua Run Shuang He Pharma Co., Ltd. romanized | 国药准字H20253790 | 2025/04/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Mu Bang (Beijing) Pharmaceuticals Technology Co., Ltd. romanized | Hua Run Shuang He Pharma Co., Ltd. romanized | 国药准字H20253792 | 2025/04/01 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Topfond Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20253444 | 2025/02/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Topfond Pharmaceutical Co., Ltd. | Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20253445 | 2025/02/25 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253081 | 2025/01/08 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hefei He Yuan Pharma Co., Ltd. romanized | Hefei He Yuan Pharma Co., Ltd. romanized | 国药准字H20253014 | 2025/01/02 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hua Run Shuang He Li Min Pharma (Jinan) Co., Ltd. romanized | Hua Run Shuang He Li Min Pharma (Jinan) Co., Ltd. romanized | 国药准字H20249412 | 2024/11/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Hua Run Shuang He Li Min Pharma (Jinan) Co., Ltd. romanized | Hua Run Shuang He Li Min Pharma (Jinan) Co., Ltd. romanized | 国药准字H20249413 | 2024/11/15 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Feng Huang Pharmaceutical Co., Ltd. romanized | Shandong Feng Huang Pharmaceutical Co., Ltd. romanized | 国药准字H20249193 | 2024/10/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Dr Reddys Laboratories Limited | Dr Reddys Laboratories Limited | 国药准字HJ20240112 | 2024/10/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Dr Reddys Laboratories Limited | Dr. Reddy's Laboratories Limited | 国药准字HJ20240113 | 2024/10/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20249024 | 2024/10/09 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Di Sha Pharma Group Co., Ltd. romanized | Di Sha Pharma Group Co., Ltd. romanized | 国药准字H20244992 | 2024/09/26 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20244371 | 2024/06/28 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20243914 | 2024/06/04 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20243915 | 2024/06/04 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20243916 | 2024/06/04 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20243656 | 2024/04/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20243657 | 2024/04/30 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Nord Pharmaceutical Co., Ltd | Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | 2024/04/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Nord Pharmaceutical Co., Ltd | Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | 2024/04/11 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Zhejiang Nord Pharmaceutical Co., Ltd | Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | 2024/04/11 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jilin Si Huan Pharmaceutical Co., Ltd. romanized | Jilin Si Huan Pharmaceutical Co., Ltd. romanized | 国药准字H20234678 | 2023/12/26 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Qilu Pharmaceutical (Hainan) Co., Ltd | Qilu Pharmaceutical (Hainan) Co., Ltd | 国药准字H20234427 | 2023/10/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Qilu Pharmaceutical (Hainan) Co., Ltd | Qilu Pharmaceutical (Hainan) Co., Ltd | 国药准字H20234426 | 2023/10/27 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20234355 | 2023/10/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Hua Han Pharmaceuticals Technology Co., Ltd. romanized | TC Pharmaceuticals (Jiangsu) Co., Ltd | 国药准字H20234348 | 2023/10/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Jiangsu Hua Han Pharmaceuticals Technology Co., Ltd. romanized | TC Pharmaceuticals (Jiangsu) Co., Ltd | 国药准字H20234347 | 2023/10/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20234354 | 2023/10/24 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Sichuan Kelun Pharmaceutical Co., Ltd. | Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20234316 | 2023/10/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Sichuan Kelun Pharmaceutical Co., Ltd. | Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20234317 | 2023/10/18 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20234256 | 2023/10/12 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20234064 | 2023/08/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | 国药准字H20234065 | 2023/08/29 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Yi Xin He Pharmaceuticals Technology Co., Ltd. romanized | Jiangsu Xuan Tai Pharma Co., Ltd. romanized | 国药准字H20234044 | 2023/08/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20234048 | 2023/08/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20234050 | 2023/08/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Yi Xin He Pharmaceuticals Technology Co., Ltd. romanized | Jiangsu Xuan Tai Pharma Co., Ltd. romanized | 国药准字H20234043 | 2023/08/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20234049 | 2023/08/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Nanjing Yi Xin He Pharmaceuticals Technology Co., Ltd. romanized | Jiangsu Xuan Tai Pharma Co., Ltd. romanized | 国药准字H20234042 | 2023/08/22 | See source | Generic approved under the new chemical-drug registration classification | CDE |
| Novartis Pharma Schweiz AG | Novartis Singapore Pharmaceutical Manufacturing Private.Ltd. | H20170364 | 2017/09/20 | 200mg | Imported originator drug | CDE |
| Novartis Pharma Schweiz AG | Novartis Singapore Pharmaceutical Manufacturing Private.Ltd. | H20170363 | 2017/09/20 | 100mg | Imported originator drug | CDE |
| Novartis Pharma Schweiz AG | Novartis Singapore Pharmaceutical Manufacturing Private.Ltd. | H20170362 | 2017/09/20 | 50mg | Imported originator drug | CDE |
| Novartis Pharma Schweiz AG | Novartis Pharma Stein AG | H20170342 | 2017/07/26 | 200mg | Imported originator drug | CDE |
| Novartis Pharma Schweiz AG | Novartis Pharma Stein AG | H20170343;国药准字J20171054 | 2017/07/26 | 100mg | Imported originator drug | CDE |
| Novartis Pharma Schweiz AG | Novartis Pharma Stein AG | H20170344 | 2017/07/26 | 50mg | Imported originator drug | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 75 distinct approval numbers and 39 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20234256 | See source | Category B | XC09DXS255A001010100553 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264915 | See source | Category B | XC09DXS255A001010101503 | NHSA |
| Jiangsu Zhong Bang Pharmaceutical Co., Ltd. romanized | 国药准字H20264960 | See source | Category B | XC09DXS255A001010101525 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20243915 | See source | Category B | XC09DXS255A001010101606 | NHSA |
| Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20255722 | See source | Category B | XC09DXS255A001010101650 | NHSA |
| Suzhou Zhong Hua Medicines Gong Ye Co., Ltd. romanized | 国药准字H20266010 | See source | Category B | XC09DXS255A001010101679 | NHSA |
| Jiangsu Hua Han Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20234347 | See source | Category B | XC09DXS255A001010101751 | NHSA |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20234354 | See source | Category B | XC09DXS255A001010102013 | NHSA |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20234316 | See source | Category B | XC09DXS255A001010102180 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001010102753 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20234048 | See source | Category B | XC09DXS255A001010102770 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20254029 | See source | Category B | XC09DXS255A001010103094 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20253445 | See source | Category B | XC09DXS255A001010103098 | NHSA |
| Jilin Si Huan Pharmaceutical Co., Ltd. romanized | 国药准字H20234678 | See source | Category B | XC09DXS255A001010103492 | NHSA |
| Hua Run Shuang He Li Min Pharma (Jinan) Co., Ltd. romanized | 国药准字H20249413 | See source | Category B | XC09DXS255A001010103973 | NHSA |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20254531 | See source | Category B | XC09DXS255A001010104043 | NHSA |
| Shandong Feng Huang Pharmaceutical Co., Ltd. romanized | 国药准字H20249193 | See source | Category B | XC09DXS255A001010104085 | NHSA |
| Shandong Lu Kang Pharmaceuticals Group Sai Te Co., Ltd. romanized | 国药准字H20265997 | See source | Category B | XC09DXS255A001010104131 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20255131 | See source | Category B | XC09DXS255A001010104187 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20249024 | See source | Category B | XC09DXS255A001010104188 | NHSA |
| Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20254480 | See source | Category B | XC09DXS255A001010104565 | NHSA |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20244371 | See source | Category B | XC09DXS255A001010104606 | NHSA |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20263294 | See source | Category B | XC09DXS255A001010105024 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20234426 | See source | Category B | XC09DXS255A001010105847 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253081 | See source | Category B | XC09DXS255A001010106632 | NHSA |
| Hefei He Yuan Pharma Co., Ltd. romanized | 国药准字H20253014 | See source | Category B | XC09DXS255A001010109541 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20255147 | See source | Category B | XC09DXS255A001010109568 | NHSA |
| Dr Reddys Laboratories Limited | 国药准字HJ20240112 | See source | Category B | XC09DXS255A001010178377 | NHSA |
| Novartis Pharma Schweiz AG | H20170343 | See source | Category B | XC09DXS255A001010178679 | NHSA |
| Hunan Qian Jin Xie Li Pharma Co., Ltd. romanized | 国药准字H20254250 | See source | Category B | XC09DXS255A001010180821 | NHSA |
| Nanjing Yi Xin He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20234043 | See source | Category B | XC09DXS255A001010181522 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264564 | See source | Category B | XC09DXS255A001010181767 | NHSA |
| Jiangsu Li Tai Er Pharma Co., Ltd. romanized | 国药准字H20255485 | See source | Category B | XC09DXS255A001010182291 | NHSA |
| Di Sha Pharma Group Co., Ltd. romanized | 国药准字H20244992 | See source | Category B | XC09DXS255A001010183063 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001010183521 | NHSA |
| Shandong Pu Rui Man Pharma Co., Ltd. romanized | 国药准字H20264365 | See source | Category B | XC09DXS255A001010184621 | NHSA |
| Jiangxi Tai Ji Li Biopharmaceuticals Technology Co., Ltd. romanized | 国药准字H20256181 | See source | Category B | XC09DXS255A001010184945 | NHSA |
| Mu Bang (Beijing) Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253790 | See source | Category B | XC09DXS255A001010184950 | NHSA |
| Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20234256 | See source | Category B | XC09DXS255A001010200553 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264915 | See source | Category B | XC09DXS255A001010201503 | NHSA |
| Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20255722 | See source | Category B | XC09DXS255A001010201650 | NHSA |
| Suzhou Zhong Hua Medicines Gong Ye Co., Ltd. romanized | 国药准字H20266010 | See source | Category B | XC09DXS255A001010201679 | NHSA |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20234354 | See source | Category B | XC09DXS255A001010202013 | NHSA |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20234316 | See source | Category B | XC09DXS255A001010202180 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001010202753 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20234048 | See source | Category B | XC09DXS255A001010202770 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20254029 | See source | Category B | XC09DXS255A001010203094 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20253445 | See source | Category B | XC09DXS255A001010203098 | NHSA |
| Jilin Si Huan Pharmaceutical Co., Ltd. romanized | 国药准字H20234678 | See source | Category B | XC09DXS255A001010203492 | NHSA |
| Hua Run Shuang He Li Min Pharma (Jinan) Co., Ltd. romanized | 国药准字H20249413 | See source | Category B | XC09DXS255A001010203973 | NHSA |
| Shandong Feng Huang Pharmaceutical Co., Ltd. romanized | 国药准字H20249193 | See source | Category B | XC09DXS255A001010204085 | NHSA |
| SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | 国药准字H20255131 | See source | Category B | XC09DXS255A001010204187 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20249024 | See source | Category B | XC09DXS255A001010204188 | NHSA |
| Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20254480 | See source | Category B | XC09DXS255A001010204565 | NHSA |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20244371 | See source | Category B | XC09DXS255A001010204606 | NHSA |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20263294 | See source | Category B | XC09DXS255A001010205024 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20234426 | See source | Category B | XC09DXS255A001010205847 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253081 | See source | Category B | XC09DXS255A001010206632 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20255147 | See source | Category B | XC09DXS255A001010209568 | NHSA |
| Dr Reddys Laboratories Limited | 国药准字HJ20240112 | See source | Category B | XC09DXS255A001010278377 | NHSA |
| Novartis Pharma Schweiz AG | H20170343 | See source | Category B | XC09DXS255A001010278679 | NHSA |
| Hunan Qian Jin Xie Li Pharma Co., Ltd. romanized | 国药准字H20254250 | See source | Category B | XC09DXS255A001010280821 | NHSA |
| Nanjing Yi Xin He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20234043 | See source | Category B | XC09DXS255A001010281522 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264564 | See source | Category B | XC09DXS255A001010281767 | NHSA |
| Jiangsu Li Tai Er Pharma Co., Ltd. romanized | 国药准字H20255485 | See source | Category B | XC09DXS255A001010282291 | NHSA |
| Di Sha Pharma Group Co., Ltd. romanized | 国药准字H20244992 | See source | Category B | XC09DXS255A001010283063 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001010283521 | NHSA |
| Shandong Pu Rui Man Pharma Co., Ltd. romanized | 国药准字H20264365 | See source | Category B | XC09DXS255A001010284621 | NHSA |
| Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | 国药准字H20234256 | See source | Category B | XC09DXS255A001010300553 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264915 | See source | Category B | XC09DXS255A001010301503 | NHSA |
| Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20255722 | See source | Category B | XC09DXS255A001010301650 | NHSA |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20234316 | See source | Category B | XC09DXS255A001010302180 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001010302753 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20234048 | See source | Category B | XC09DXS255A001010302770 | NHSA |
| Le Pu Pharma Co., Ltd. romanized | 国药准字H20254029 | See source | Category B | XC09DXS255A001010303094 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20253445 | See source | Category B | XC09DXS255A001010303098 | NHSA |
| Jilin Si Huan Pharmaceutical Co., Ltd. romanized | 国药准字H20234678 | See source | Category B | XC09DXS255A001010303492 | NHSA |
| Hua Run Shuang He Li Min Pharma (Jinan) Co., Ltd. romanized | 国药准字H20249413 | See source | Category B | XC09DXS255A001010303973 | NHSA |
| Shandong Feng Huang Pharmaceutical Co., Ltd. romanized | 国药准字H20249193 | See source | Category B | XC09DXS255A001010304085 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20249024 | See source | Category B | XC09DXS255A001010304188 | NHSA |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20244371 | See source | Category B | XC09DXS255A001010304606 | NHSA |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20263294 | See source | Category B | XC09DXS255A001010305024 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253081 | See source | Category B | XC09DXS255A001010306632 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20255147 | See source | Category B | XC09DXS255A001010309568 | NHSA |
| Dr Reddys Laboratories Limited | 国药准字HJ20240112 | See source | Category B | XC09DXS255A001010378377 | NHSA |
| Novartis Pharma Schweiz AG | 国药准字HJ20170363 | See source | Category B | XC09DXS255A001010378679 | NHSA |
| Hunan Qian Jin Xie Li Pharma Co., Ltd. romanized | 国药准字H20254250 | See source | Category B | XC09DXS255A001010380821 | NHSA |
| Nanjing Yi Xin He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20234043 | See source | Category B | XC09DXS255A001010381522 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264564 | See source | Category B | XC09DXS255A001010381767 | NHSA |
| Di Sha Pharma Group Co., Ltd. romanized | 国药准字H20244992 | See source | Category B | XC09DXS255A001010383063 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001010383521 | NHSA |
| Shandong Pu Rui Man Pharma Co., Ltd. romanized | 国药准字H20264365 | See source | Category B | XC09DXS255A001010384621 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264915 | See source | Category B | XC09DXS255A001010401503 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001010402753 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20234048 | See source | Category B | XC09DXS255A001010402770 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20253445 | See source | Category B | XC09DXS255A001010403098 | NHSA |
| Jilin Si Huan Pharmaceutical Co., Ltd. romanized | 国药准字H20234678 | See source | Category B | XC09DXS255A001010403492 | NHSA |
| Shandong Feng Huang Pharmaceutical Co., Ltd. romanized | 国药准字H20249193 | See source | Category B | XC09DXS255A001010404085 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20249024 | See source | Category B | XC09DXS255A001010404188 | NHSA |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20244371 | See source | Category B | XC09DXS255A001010404606 | NHSA |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20263294 | See source | Category B | XC09DXS255A001010405024 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253081 | See source | Category B | XC09DXS255A001010406632 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20255147 | See source | Category B | XC09DXS255A001010409568 | NHSA |
| Novartis Pharma Schweiz AG | 国药准字HJ20170363 | See source | Category B | XC09DXS255A001010478679 | NHSA |
| Nanjing Yi Xin He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20234043 | See source | Category B | XC09DXS255A001010481522 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264564 | See source | Category B | XC09DXS255A001010481767 | NHSA |
| Di Sha Pharma Group Co., Ltd. romanized | 国药准字H20244992 | See source | Category B | XC09DXS255A001010483063 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001010483521 | NHSA |
| Shandong Pu Rui Man Pharma Co., Ltd. romanized | 国药准字H20264365 | See source | Category B | XC09DXS255A001010484621 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264915 | See source | Category B | XC09DXS255A001010501503 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001010502753 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20234048 | See source | Category B | XC09DXS255A001010502770 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20253445 | See source | Category B | XC09DXS255A001010503098 | NHSA |
| Shandong Feng Huang Pharmaceutical Co., Ltd. romanized | 国药准字H20249193 | See source | Category B | XC09DXS255A001010504085 | NHSA |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20263294 | See source | Category B | XC09DXS255A001010505024 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253081 | See source | Category B | XC09DXS255A001010506632 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20255147 | See source | Category B | XC09DXS255A001010509568 | NHSA |
| Nanjing Yi Xin He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20234043 | See source | Category B | XC09DXS255A001010581522 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264564 | See source | Category B | XC09DXS255A001010581767 | NHSA |
| Di Sha Pharma Group Co., Ltd. romanized | 国药准字H20244992 | See source | Category B | XC09DXS255A001010583063 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001010583521 | NHSA |
| Shandong Pu Rui Man Pharma Co., Ltd. romanized | 国药准字H20264365 | See source | Category B | XC09DXS255A001010584621 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264915 | See source | Category B | XC09DXS255A001010601503 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001010602753 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20234048 | See source | Category B | XC09DXS255A001010602770 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20253445 | See source | Category B | XC09DXS255A001010603098 | NHSA |
| Shandong Feng Huang Pharmaceutical Co., Ltd. romanized | 国药准字H20249193 | See source | Category B | XC09DXS255A001010604085 | NHSA |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20263294 | See source | Category B | XC09DXS255A001010605024 | NHSA |
| Jiangsu Deyuan Pharmaceutical Co.,Ltd. | 国药准字H20253081 | See source | Category B | XC09DXS255A001010606632 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264564 | See source | Category B | XC09DXS255A001010681767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001010683521 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001010702753 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20234048 | See source | Category B | XC09DXS255A001010702770 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264564 | See source | Category B | XC09DXS255A001010781767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001010783521 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001010802753 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264564 | See source | Category B | XC09DXS255A001010881767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001010883521 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001010902753 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264564 | See source | Category B | XC09DXS255A001010981767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001010983521 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001011002753 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264564 | See source | Category B | XC09DXS255A001011081767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001011083521 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001011102753 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264564 | See source | Category B | XC09DXS255A001011181767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001011183521 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001011202753 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264564 | See source | Category B | XC09DXS255A001011281767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001011283521 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001011302753 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001011383521 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001011402753 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001011483521 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001011502753 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001011583521 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001011602753 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001011683521 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001011702753 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001011783521 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001011802753 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001011883521 | NHSA |
| Shijiazhuang Shi Hua Xin Pharma Co., Ltd. romanized | 国药准字H20265959 | See source | Category B | XC09DXS255A001011902753 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001011983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001012083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001012183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001012283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001012383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001012483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001012583521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001012683521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001012783521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001012883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001012983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001013083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001013183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001013283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001013383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001013483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243476 | See source | Category B | XC09DXS255A001013583521 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264914 | See source | Category B | XC09DXS255A001020101503 | NHSA |
| Jiangsu Zhong Bang Pharmaceutical Co., Ltd. romanized | 国药准字H20264961 | See source | Category B | XC09DXS255A001020101525 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20243916 | See source | Category B | XC09DXS255A001020101606 | NHSA |
| Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20255723 | See source | Category B | XC09DXS255A001020101650 | NHSA |
| Jiangsu Hua Han Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20234348 | See source | Category B | XC09DXS255A001020101751 | NHSA |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20234355 | See source | Category B | XC09DXS255A001020102013 | NHSA |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20234317 | See source | Category B | XC09DXS255A001020102180 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20234049 | See source | Category B | XC09DXS255A001020102770 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20253444 | See source | Category B | XC09DXS255A001020103098 | NHSA |
| Hua Run Shuang He Li Min Pharma (Jinan) Co., Ltd. romanized | 国药准字H20249412 | See source | Category B | XC09DXS255A001020103973 | NHSA |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20254532 | See source | Category B | XC09DXS255A001020104043 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20258258 | See source | Category B | XC09DXS255A001020104188 | NHSA |
| Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20254481 | See source | Category B | XC09DXS255A001020104565 | NHSA |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20258280 | See source | Category B | XC09DXS255A001020104606 | NHSA |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20263293 | See source | Category B | XC09DXS255A001020105024 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20234427 | See source | Category B | XC09DXS255A001020105847 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20255148 | See source | Category B | XC09DXS255A001020109568 | NHSA |
| Dr Reddys Laboratories Limited | 国药准字HJ20240113 | See source | Category B | XC09DXS255A001020178377 | NHSA |
| Novartis Pharma Schweiz AG | H20170344 | See source | Category B | XC09DXS255A001020178679 | NHSA |
| Hunan Qian Jin Xie Li Pharma Co., Ltd. romanized | 国药准字H20254868 | See source | Category B | XC09DXS255A001020180821 | NHSA |
| Nanjing Yi Xin He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20234044 | See source | Category B | XC09DXS255A001020181522 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264565 | See source | Category B | XC09DXS255A001020181767 | NHSA |
| Jiangsu Li Tai Er Pharma Co., Ltd. romanized | 国药准字H20255486 | See source | Category B | XC09DXS255A001020182291 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001020183521 | NHSA |
| Mu Bang (Beijing) Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253791 | See source | Category B | XC09DXS255A001020184950 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264914 | See source | Category B | XC09DXS255A001020201503 | NHSA |
| Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20255723 | See source | Category B | XC09DXS255A001020201650 | NHSA |
| Chengdu Brilliant Pharmaceutical Co., Ltd. | 国药准字H20234355 | See source | Category B | XC09DXS255A001020202013 | NHSA |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20234317 | See source | Category B | XC09DXS255A001020202180 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20253444 | See source | Category B | XC09DXS255A001020203098 | NHSA |
| Hua Run Shuang He Li Min Pharma (Jinan) Co., Ltd. romanized | 国药准字H20249412 | See source | Category B | XC09DXS255A001020203973 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20258258 | See source | Category B | XC09DXS255A001020204188 | NHSA |
| Ningbo Menovo Tiankang Pharmaceutical Co., Ltd. | 国药准字H20254481 | See source | Category B | XC09DXS255A001020204565 | NHSA |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20258280 | See source | Category B | XC09DXS255A001020204606 | NHSA |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20263293 | See source | Category B | XC09DXS255A001020205024 | NHSA |
| Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20234427 | See source | Category B | XC09DXS255A001020205847 | NHSA |
| Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | 国药准字H20255148 | See source | Category B | XC09DXS255A001020209568 | NHSA |
| Dr Reddys Laboratories Limited | 国药准字HJ20240113 | See source | Category B | XC09DXS255A001020278377 | NHSA |
| Novartis Pharma Schweiz AG | H20170344 | See source | Category B | XC09DXS255A001020278679 | NHSA |
| Hunan Qian Jin Xie Li Pharma Co., Ltd. romanized | 国药准字H20254868 | See source | Category B | XC09DXS255A001020280821 | NHSA |
| Nanjing Yi Xin He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20234044 | See source | Category B | XC09DXS255A001020281522 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264565 | See source | Category B | XC09DXS255A001020281767 | NHSA |
| Jiangsu Li Tai Er Pharma Co., Ltd. romanized | 国药准字H20255486 | See source | Category B | XC09DXS255A001020282291 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001020283521 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264914 | See source | Category B | XC09DXS255A001020301503 | NHSA |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 国药准字H20234317 | See source | Category B | XC09DXS255A001020302180 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20253444 | See source | Category B | XC09DXS255A001020303098 | NHSA |
| Hua Run Shuang He Li Min Pharma (Jinan) Co., Ltd. romanized | 国药准字H20249412 | See source | Category B | XC09DXS255A001020303973 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20258258 | See source | Category B | XC09DXS255A001020304188 | NHSA |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20258280 | See source | Category B | XC09DXS255A001020304606 | NHSA |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20263293 | See source | Category B | XC09DXS255A001020305024 | NHSA |
| Dr Reddys Laboratories Limited | 国药准字HJ20240113 | See source | Category B | XC09DXS255A001020378377 | NHSA |
| Novartis Pharma Schweiz AG | 国药准字HJ20170362 | See source | Category B | XC09DXS255A001020378679 | NHSA |
| Hunan Qian Jin Xie Li Pharma Co., Ltd. romanized | 国药准字H20254868 | See source | Category B | XC09DXS255A001020380821 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264565 | See source | Category B | XC09DXS255A001020381767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001020383521 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264914 | See source | Category B | XC09DXS255A001020401503 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20253444 | See source | Category B | XC09DXS255A001020403098 | NHSA |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized | 国药准字H20258258 | See source | Category B | XC09DXS255A001020404188 | NHSA |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20258280 | See source | Category B | XC09DXS255A001020404606 | NHSA |
| Hunan Wei Te Pharmaceutical Co., Ltd. romanized | 国药准字H20263293 | See source | Category B | XC09DXS255A001020405024 | NHSA |
| Novartis Pharma Schweiz AG | 国药准字HJ20170362 | See source | Category B | XC09DXS255A001020478679 | NHSA |
| Hunan Qian Jin Xie Li Pharma Co., Ltd. romanized | 国药准字H20254868 | See source | Category B | XC09DXS255A001020480821 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264565 | See source | Category B | XC09DXS255A001020481767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001020483521 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264914 | See source | Category B | XC09DXS255A001020501503 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20253444 | See source | Category B | XC09DXS255A001020503098 | NHSA |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 国药准字H20258280 | See source | Category B | XC09DXS255A001020504606 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264565 | See source | Category B | XC09DXS255A001020581767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001020583521 | NHSA |
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | 国药准字H20264914 | See source | Category B | XC09DXS255A001020601503 | NHSA |
| Topfond Pharmaceutical Co., Ltd. | 国药准字H20253444 | See source | Category B | XC09DXS255A001020603098 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264565 | See source | Category B | XC09DXS255A001020681767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001020683521 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264565 | See source | Category B | XC09DXS255A001020781767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001020783521 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264565 | See source | Category B | XC09DXS255A001020881767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001020883521 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264565 | See source | Category B | XC09DXS255A001020981767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001020983521 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264565 | See source | Category B | XC09DXS255A001021081767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001021083521 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264565 | See source | Category B | XC09DXS255A001021181767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001021183521 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264565 | See source | Category B | XC09DXS255A001021281767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001021283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001021383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001021483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001021583521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001021683521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001021783521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001021883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001021983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001022083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001022183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001022283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001022383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001022483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001022583521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001022683521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001022783521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001022883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001022983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001023083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001023183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001023283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001023383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001023483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243477 | See source | Category B | XC09DXS255A001023583521 | NHSA |
| Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 国药准字H20243914 | See source | Category B | XC09DXS255A001030101606 | NHSA |
| Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20255724 | See source | Category B | XC09DXS255A001030101650 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20234050 | See source | Category B | XC09DXS255A001030102770 | NHSA |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | 国药准字H20254533 | See source | Category B | XC09DXS255A001030104043 | NHSA |
| Nanjing Yi Xin He Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20234043 | See source | Category B | XC09DXS255A001030181522 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264566 | See source | Category B | XC09DXS255A001030181767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001030183521 | NHSA |
| Mu Bang (Beijing) Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20253792 | See source | Category B | XC09DXS255A001030184950 | NHSA |
| Suzhou Dong Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20255724 | See source | Category B | XC09DXS255A001030201650 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20234050 | See source | Category B | XC09DXS255A001030202770 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264566 | See source | Category B | XC09DXS255A001030281767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001030283521 | NHSA |
| Novartis Pharma Schweiz AG | 国药准字HJ20170364 | See source | Category B | XC09DXS255A001030378679 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264566 | See source | Category B | XC09DXS255A001030381767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001030383521 | NHSA |
| Novartis Pharma Schweiz AG | 国药准字HJ20170364 | See source | Category B | XC09DXS255A001030478679 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264566 | See source | Category B | XC09DXS255A001030481767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001030483521 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264566 | See source | Category B | XC09DXS255A001030581767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001030583521 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264566 | See source | Category B | XC09DXS255A001030681767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001030683521 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264566 | See source | Category B | XC09DXS255A001030781767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001030783521 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264566 | See source | Category B | XC09DXS255A001030881767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001030883521 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264566 | See source | Category B | XC09DXS255A001030981767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001030983521 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264566 | See source | Category B | XC09DXS255A001031081767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001031083521 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264566 | See source | Category B | XC09DXS255A001031181767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001031183521 | NHSA |
| Liaoning Xin Shan Yuan Pharma Co., Ltd. romanized | 国药准字H20264566 | See source | Category B | XC09DXS255A001031281767 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001031283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001031383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001031483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001031583521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001031683521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001031783521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001031883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001031983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001032083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001032183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001032283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001032383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001032483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001032583521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001032683521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001032783521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001032883521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001032983521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001033083521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001033183521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001033283521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001033383521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001033483521 | NHSA |
| Zhejiang Nord Pharmaceutical Co., Ltd | 国药准字H20243620 | See source | Category B | XC09DXS255A001033583521 | NHSA |
| Novartis Pharma Schweiz AG | 国药准字HJ20170364 | See source | Category B | XC09DXS255A001050178679 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20243656 | See source | Category B | XC09DXS255A001010101397 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20243656 | See source | Category B | XC09DXS255A001010201397 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20243656 | See source | Category B | XC09DXS255A001010301397 | NHSA |
| CSPC OUYI PHARMACEUTICAL CO., LTD. | 国药准字H20234048 | See source | Category B | XC09DXS255A001010802770 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20243657 | See source | Category B | XC09DXS255A001020101397 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20243657 | See source | Category B | XC09DXS255A001020201397 | NHSA |
| Changzhou Pharmaceutical Factory Co., Ltd. romanized | 国药准字H20243657 | See source | Category B | XC09DXS255A001020301397 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 70 filings and 34 distinct first applicants.
Generic 57 · Supplement 13
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Beijing Kang Li Sheng Pharmaceuticals Technology Kai Fa Co., Ltd. romanized; Shandong Wei Zhi Bai Ke Pharma Co., Ltd. romanized | CYHS2602518 | Generic | 2026/10/13 | Not stated by source | CDE |
| Beijing Kang Li Sheng Pharmaceuticals Technology Kai Fa Co., Ltd. romanized; Shandong Wei Zhi Bai Ke Pharma Co., Ltd. romanized | CYHS2602517 | Generic | 2026/10/13 | Not stated by source | CDE |
| Shenyang Ao Ji Na Pharma Co., Ltd. romanized | CYHB2601870 | Supplement | 2026/10/12 | Not stated by source | CDE |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | CYHS2602484 | Generic | 2026/10/10 | Not stated by source | CDE |
| Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized | CYHS2602483 | Generic | 2026/10/10 | Not stated by source | CDE |
| Suzhou Zhong Hua Medicines Gong Ye Co., Ltd. romanized | CYHB2601822 | Supplement | 2026/09/29 | Not stated by source | CDE |
| Yan Tai Lu Yin Pharma Co., Ltd. romanized | CYHS2602352 | Generic | 2026/09/20 | Not stated by source | CDE |
| Yan Tai Lu Yin Pharma Co., Ltd. romanized | CYHS2602351 | Generic | 2026/09/20 | Not stated by source | CDE |
| Jiangsu Shen Hua Pharma Co., Ltd. romanized | CYHB2601491 | Supplement | 2026/08/04 | Not stated by source | CDE |
| Novartis Pharma Schweiz AG; Novartis Farma S.p.A. | JYHB2600421 | Supplement | 2026/07/28 | Not stated by source | CDE |
| Novartis Pharma Schweiz AG; Novartis Farma S.p.A. | JYHB2600420 | Supplement | 2026/07/28 | Not stated by source | CDE |
| Novartis Pharma Schweiz AG; Novartis Farma S.p.A. | JYHB2600419 | Supplement | 2026/07/28 | Not stated by source | CDE |
| Changzhou Si Yao Pharmaceutical Co., Ltd. romanized | CYHS2601764 | Generic | 2026/07/22 | Not stated by source | CDE |
| Changzhou Si Yao Pharmaceutical Co., Ltd. romanized | CYHS2601763 | Generic | 2026/07/22 | Not stated by source | CDE |
| Rui Yang Pharmaceutical Co., Ltd. romanized | CYHS2601354 | Generic | 2026/06/10 | Not stated by source | CDE |
| Rui Yang Pharmaceutical Co., Ltd. romanized | CYHS2601353 | Generic | 2026/06/10 | Not stated by source | CDE |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized; Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CYHS2601152 | Generic | 2026/05/14 | Not stated by source | CDE |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized; Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CYHS2601151 | Generic | 2026/05/14 | Not stated by source | CDE |
| Yun Peng Pharmaceuticals Group Co., Ltd. romanized; Jiangsu Cheng Kang Pharma Co., Ltd. romanized | CYHS2601150 | Generic | 2026/05/14 | Not stated by source | CDE |
| Henan Zhong Jie Pharma Co., Ltd. romanized | CYHS2601128 | Generic | 2026/05/14 | Not stated by source | CDE |
| Henan Zhong Jie Pharma Co., Ltd. romanized | CYHS2601127 | Generic | 2026/05/14 | Not stated by source | CDE |
| Henan Zhong Jie Pharma Co., Ltd. romanized | CYHS2601124 | Generic | 2026/05/14 | Not stated by source | CDE |
| Yi Nan Li Nuo Pharmaceutical Co., Ltd. romanized | CYHS2600918 | Generic | 2026/04/22 | Not stated by source | CDE |
| Yi Nan Li Nuo Pharmaceutical Co., Ltd. romanized | CYHS2600917 | Generic | 2026/04/22 | Not stated by source | CDE |
| Sichuan Bai Li Pharma Co., Ltd. romanized | CYHS2600691 | Generic | 2026/03/21 | Not stated by source | CDE |
| HAINAN HUALON PHARMACEUTICAL CO.,LTD | CYHS2600635 | Generic | 2026/03/10 | Not stated by source | CDE |
| HAINAN HUALON PHARMACEUTICAL CO.,LTD | CYHS2600634 | Generic | 2026/03/10 | Not stated by source | CDE |
| Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | CYHS2600473 | Generic | 2026/02/13 | Not stated by source | CDE |
| Guo Yao Group Zhi Jun (Shenzhen) Ping Shan Pharmaceutical Co., Ltd. romanized | CYHS2600472 | Generic | 2026/02/13 | Not stated by source | CDE |
| Novartis Pharma Schweiz AG; Novartis Farma S.p.A.; Novartis Pharmaceutical Manufacturing LLC | JYHB2600021 | Supplement | 2026/01/07 | Not stated by source | CDE |
| Novartis Pharma Schweiz AG; Novartis Farma S.p.A.; Novartis Pharmaceutical Manufacturing LLC | JYHB2600020 | Supplement | 2026/01/07 | Not stated by source | CDE |
| Novartis Pharma Schweiz AG; Novartis Farma S.p.A.; Novartis Pharmaceutical Manufacturing LLC | JYHB2600019 | Supplement | 2026/01/07 | Not stated by source | CDE |
| Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CYHS2502914 | Generic | 2025/08/11 | Not stated by source | CDE |
| Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CYHS2502913 | Generic | 2025/08/11 | Not stated by source | CDE |
| Jiangsu Yong An Pharmaceutical Co., Ltd. romanized | CYHS2502778 | Generic | 2025/08/02 | Not stated by source | CDE |
| Jiangsu Yong An Pharmaceutical Co., Ltd. romanized | CYHS2502777 | Generic | 2025/08/02 | Not stated by source | CDE |
| Fu Xing Wan Bang (Jiangsu) Pharmaceuticals Group Co., Ltd. romanized; Fu Xing Pharmaceuticals (Xu Zhou) Co., Ltd. romanized | CYHS2502488 | Generic | 2025/07/12 | Not stated by source | CDE |
| Shenzhen Xin Li Tai Pharma Co., Ltd. romanized | CYHB2502609 | Supplement | 2025/12/30 | Not stated by source | CDE |
| Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized; Chongqing Xi Nan Pharmaceutical Er Factory Co., Ltd. romanized | CYHS2504456 | Generic | 2025/12/29 | Not stated by source | CDE |
| Jiangxi Ban Bian Tian Pharma Co., Ltd. romanized; Chongqing Xi Nan Pharmaceutical Er Factory Co., Ltd. romanized | CYHS2504455 | Generic | 2025/12/29 | Not stated by source | CDE |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | CYHS2504032 | Generic | 2025/11/21 | Not stated by source | CDE |
| Sichuan Yi Ke Pharmaceutical Co., Ltd. romanized | CYHS2504031 | Generic | 2025/11/21 | Not stated by source | CDE |
| Shandong Nuo Ming Kang Drug Research Institute Co., Ltd. romanized; Shandong Zi Bo Xin Da Pharmaceutical Co., Ltd. romanized | CYHS2503714 | Generic | 2025/10/17 | Not stated by source | CDE |
| Beijing Heng Sheng Pharma Co., Ltd. romanized | CYHS2503704 | Generic | 2025/10/16 | Not stated by source | CDE |
| Beijing Heng Sheng Pharma Co., Ltd. romanized | CYHS2503702 | Generic | 2025/10/16 | Not stated by source | CDE |
| Zhejiang Hua Hai Pharmaceutical Technology Co., Ltd. romanized | CYHS2503583 | Generic | 2025/09/29 | Not stated by source | CDE |
| Zhejiang Hua Hai Pharmaceutical Technology Co., Ltd. romanized | CYHS2503582 | Generic | 2025/09/29 | Not stated by source | CDE |
| Zhejiang Hua Hai Pharmaceutical Technology Co., Ltd. romanized | CYHS2503581 | Generic | 2025/09/29 | Not stated by source | CDE |
| Nanchang Shi Fei Hong Pharma Co., Ltd. romanized | CYHS2503359 | Generic | 2025/09/10 | Not stated by source | CDE |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | CYHS2503276 | Generic | 2025/09/05 | Not stated by source | CDE |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | CYHS2503275 | Generic | 2025/09/05 | Not stated by source | CDE |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | CYHS2503274 | Generic | 2025/09/05 | Not stated by source | CDE |
| Chongqing Pharmaceuticals (Group) Co., Ltd. romanized; Zhi En Bio Technology Co., Ltd. romanized | CYHS2503230 | Generic | 2025/09/02 | Not stated by source | CDE |
| Chongqing Pharmaceuticals (Group) Co., Ltd. romanized; Zhi En Bio Technology Co., Ltd. romanized | CYHS2503229 | Generic | 2025/09/02 | Not stated by source | CDE |
| Chongqing Pharmaceuticals (Group) Co., Ltd. romanized; Zhi En Bio Technology Co., Ltd. romanized | CYHS2503228 | Generic | 2025/09/02 | Not stated by source | CDE |
| Jiangxi Shimei Pharmaceutical Co., Ltd | CYHS2502976 | Generic | 2025/08/14 | Not stated by source | CDE |
| Jiangxi Shimei Pharmaceutical Co., Ltd | CYHS2502975 | Generic | 2025/08/14 | Not stated by source | CDE |
| Jiangxi Shimei Pharmaceutical Co., Ltd | CYHS2502974 | Generic | 2025/08/14 | Not stated by source | CDE |
| Beijing SL Pharmaceutical Co., Ltd. | CYHS2502827 | Generic | 2025/08/06 | Not stated by source | CDE |
| Beijing SL Pharmaceutical Co., Ltd. | CYHS2502826 | Generic | 2025/08/06 | Not stated by source | CDE |
| NORTH CHINA PHARMACEUTICAL COMPANY.LTD | CYHS2501403 | Generic | 2025/04/11 | Not stated by source | CDE |
| NORTH CHINA PHARMACEUTICAL COMPANY.LTD | CYHS2501402 | Generic | 2025/04/11 | Not stated by source | CDE |
| Hua Zhong Pharma Co., Ltd. romanized | CYHS2404088 | Generic | 2024/11/28 | Not stated by source | CDE |
| Hua Zhong Pharma Co., Ltd. romanized | CYHS2404087 | Generic | 2024/11/28 | Not stated by source | CDE |
| Hua Zhong Pharma Co., Ltd. romanized | CYHS2404086 | Generic | 2024/11/28 | Not stated by source | CDE |
| Hunan Tian Ji Cao Tang Pharmaceutical Co., Ltd. romanized | CYHS2403870 | Generic | 2024/11/12 | Not stated by source | CDE |
| Hunan Tian Ji Cao Tang Pharmaceutical Co., Ltd. romanized | CYHS2403869 | Generic | 2024/11/12 | Not stated by source | CDE |
| TIANJIN LISHENG PHARMACEUTICAL CO., LTD | CYHB2601980 | Supplement | 2026/10/29 | Not stated by source | CDE |
| Sen Long Pharma Co., Ltd. romanized; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CYHB2602027 | Supplement | 2026/11/09 | Not stated by source | CDE |
| Sen Long Pharma Co., Ltd. romanized; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD | CYHB2602026 | Supplement | 2026/11/09 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 23 filings and 11 distinct first applicants.
API registrations
Non-component matches: 28 companies with A status and 8 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 沙库巴曲缬沙坦钠 · No verified English name | Zhejiang Rui Bo Pharmaceutical Co., Ltd. romanized | Y20260000696 | I | Exact ingredient | 2026/08/11 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Rui Yang Pharmaceutical Co., Ltd. romanized | Y20260000280 | I | Exact ingredient | 2026/05/08 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Shandong Lukang Pharmaceutical Co.,Ltd. | Y20260000222 | I | Exact ingredient | 2026/04/13 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Zhejiang Pu Luo Jia Yuan Pharma Co., Ltd. romanized | Y20250001455 | I | Exact ingredient | 2026/01/12 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Shandong Ke Yuan Pharmaceutical Co., Ltd. romanized | Y20250000880 | I | Exact ingredient | 2025/08/28 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Chongqing Xi Nan Pharmaceutical Er Factory Co., Ltd. romanized | Y20250000556 | I | Exact ingredient | 2025/06/19 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Jiangxi Long Lai Biopharmaceutical Co., Ltd. romanized | Y20250000253 | A | Exact ingredient | 2026/07/31 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Gansu Hao Tian Pharmaceuticals Technology Co., Ltd. romanized | Y20250000170 | A | Exact ingredient | 2026/09/01 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD. | Y20240001522 | A | Exact ingredient | 2026/06/11 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Hunan Xian Shi Pharmaceutical Co., Ltd. romanized | Y20240001500 | I | Exact ingredient | 2024/12/26 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Shandong Ke Chao Biopharmaceutical Co., Ltd. romanized | Y20240001078 | A | Exact ingredient | 2026/03/30 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | Y20240000743 | A | Exact ingredient | 2026/01/16 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Chongqing Sheng Hua Xi Pharma Co., Ltd. romanized | Y20230001382 | A | Exact ingredient | 2026/09/29 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Hua Zhong Pharma Co., Ltd. romanized | Y20230001132 | A | Exact ingredient | 2025/08/29 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Shree Jee Laboratory Pvt. Ltd. | Y20220001052 | I | Exact ingredient | 2023/10/24 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED | Y20230000980 | A | Exact ingredient | 2025/06/09 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Hefei He Yuan Pharma Co., Ltd. romanized | Y20230000750 | A | Exact ingredient | 2025/01/13 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Xuan Cheng Mei Nuo Hua Pharma Co., Ltd. romanized | Y20230000494 | A | Exact ingredient | 2026/09/18 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Hua Bei Pharmaceutical Hua Sheng Co., Ltd. romanized | Y20230000556 | A | Exact ingredient | 2026/04/27 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Zhejiang Mei Nuo Hua Drug Chemical Co., Ltd. romanized | Y20220000683 | A | Exact ingredient | 2024/12/16 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Shandong Xin Shi Dai Pharma Co., Ltd. romanized | Y20220000888 | A | Exact ingredient | 2024/09/02 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Zhejiang Tian Yu Pharma Co., Ltd. romanized | Y20220000721 | A | Exact ingredient | 2026/04/09 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Liao Yuan Shi Yin Ying Pharmaceutical Co., Ltd. romanized | Y20220000606 | A | Exact ingredient | 2025/04/16 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Jiangxi Long Lai Biopharmaceutical Co., Ltd. romanized | Y20220000544 | A | Exact ingredient | 2024/05/28 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Jiangsu Hui Ju Pharma Co., Ltd. romanized | Y20220000067 | A | Exact ingredient | 2025/12/02 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Dr. Reddy’s Laboratories Ltd. | Y20210000878 | A | Exact ingredient | 2024/09/30 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Shandong An Hong Pharmaceutical Co., Ltd. romanized | Y20210000945 | A | Exact ingredient | 2026/08/27 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Nan Tong Chang You Pharma Technology Co., Ltd. romanized | Y20210000934 | A | Exact ingredient | 2026/10/05 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Jiangsu Lianhuan Pharmaceutical Co.,Ltd. | Y20200001345 | A | Exact ingredient | 2024/06/15 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Sichuan Kelun Pharmaceutical Co., Ltd. | Y20210000407 | A | Exact ingredient | 2025/09/15 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Zhuhai Run Dou Pharmaceutical Co., Ltd. romanized | Y20200001073 | A | Exact ingredient | 2024/11/30 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Di Jia Pharma Group Co., Ltd. romanized | Y20200001422 | A | Exact ingredient | 2024/10/29 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Sichuan Ren An Pharma Co., Ltd. romanized | Y20200000676 | A | Exact ingredient | 2025/05/20 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Jilin Hui Kang Pharmaceutical Co., Ltd. romanized | Y20190001061 | A | Exact ingredient | 2024/01/05 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Hui Zhou Xin Li Tai Pharma Co., Ltd. romanized | Y20190000069 | A | Exact ingredient | 2024/03/28 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Lian Yun Gang Run Zhong Pharmaceutical Co., Ltd. romanized | Y20190000088 | A | Exact ingredient | 2024/06/06 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | CSPC OUYI PHARMACEUTICAL CO., LTD. | Y20180001658 | A | Exact ingredient | 2025/05/31 | CDE |
| 沙库巴曲缬沙坦钠 · No verified English name | Jiangsu Yong Da Pharma Co., Ltd. romanized | Y20180001220 | A | Exact ingredient | 2023/12/08 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/11/09Accepted
Sen Long Pharma Co., Ltd. romanized; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD
CYHB2602027
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗ -
2026/11/09Accepted
Sen Long Pharma Co., Ltd. romanized; CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD
CYHB2602026
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗ -
2026/11/07No longer listed under review
Le Pu Pharma Co., Ltd. romanized
CYHB2601398
Fact date: 2026/11/07 · Site observation date: 2026/11/07
Accepted: 2026/07/22
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 21
NMPA · Table row 21 ↗ View source ↗ -
2026/11/07No longer listed under review
SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED; Xin Hua Pharmaceutical (Gao Mi) Co., Ltd. romanized
CYHB2601384
Fact date: 2026/11/07 · Site observation date: 2026/11/07
Accepted: 2026/07/21
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 20
NMPA · Table row 20 ↗ View source ↗ -
2026/11/06No longer listed under review
Hainan Huluwa Pharmaceutical Group Co., Ltd.
CYHS2401434
Fact date: 2026/11/06 · Site observation date: 2026/11/06
Accepted: 2024/05/13
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/11/06No longer listed under review
Hainan Huluwa Pharmaceutical Group Co., Ltd.
CYHS2401433
Fact date: 2026/11/06 · Site observation date: 2026/11/06
Accepted: 2024/05/13
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/11/05Supplement delivery
Le Pu Pharma Co., Ltd. romanized
CYHB2601398
Fact date: 2026/11/05 · Publication date: 2026/11/06 · Site observation date: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 21 ↗ -
2026/11/05Supplement delivery
SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED
CYHB2601384
Fact date: 2026/11/05 · Publication date: 2026/11/06 · Site observation date: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 20 ↗ -
2026/11/04Notification delivery
Hainan Sai Li Ke Pharma Co., Ltd. romanized
CYHS2501179
Fact date: 2026/11/04 (Publication date) · Publication date: 2026/11/04 · Site observation date: 2026/11/04
Notification delivered; the specific outcome remains to be checked.
View source · Table row 4 ↗ -
2026/11/04No longer listed under review
Di Sha Pharma Group Co., Ltd. romanized
CYHB2601374
Fact date: 2026/11/04 · Site observation date: 2026/11/04
Accepted: 2026/07/20
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/03 (approval no.: —; approval date: 2026/11/02); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 6
NMPA · Table row 6 ↗ View source ↗ -
2026/11/04No longer listed under review
Di Sha Pharma Group Co., Ltd. romanized
CYHB2601373
Fact date: 2026/11/04 · Site observation date: 2026/11/04
Accepted: 2026/07/20
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/03 (approval no.: —; approval date: 2026/11/02); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 5
NMPA · Table row 5 ↗ View source ↗ -
2026/11/03Marketing application approved
Shijiazhuang No.4 Pharmaceutical Co., Ltd.
CYHS2502050 · 国药准字H20266451
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Site observation date: 2026/11/06
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 82 ↗ -
2026/11/02Supplement delivery
Di Sha Pharma Group Co., Ltd. romanized
CYHB2601374
Fact date: 2026/11/02 · Publication date: 2026/11/03 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 6 ↗ -
2026/11/02Supplement delivery
Di Sha Pharma Group Co., Ltd. romanized
CYHB2601373
Fact date: 2026/11/02 · Publication date: 2026/11/03 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 5 ↗ -
2026/10/31No longer listed under review
Hunan Wei Te Pharmaceutical Co., Ltd. romanized
CYHB2601317
Fact date: 2026/10/31 · Site observation date: 2026/10/31
Accepted: 2026/07/10
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/30 (approval no.: —; approval date: 2026/10/29); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 7
NMPA · Table row 7 ↗ View source ↗ -
2026/10/31No longer listed under review
Hunan Wei Te Pharmaceutical Co., Ltd. romanized
CYHB2601316
Fact date: 2026/10/31 · Site observation date: 2026/10/31
Accepted: 2026/07/10
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/30 (approval no.: —; approval date: 2026/10/29); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 6
NMPA · Table row 6 ↗ View source ↗ -
2026/10/31No longer listed under review
Jiangsu Vanguard Pharmaceutical Co., Ltd.
CYHB2601287
Fact date: 2026/10/31 · Site observation date: 2026/10/31
Accepted: 2026/07/08
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/30 (approval no.: —; approval date: 2026/10/29); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 5
NMPA · Table row 5 ↗ View source ↗ -
2026/10/31No longer listed under review
Jiangsu Vanguard Pharmaceutical Co., Ltd.
CYHB2601286
Fact date: 2026/10/31 · Site observation date: 2026/10/31
Accepted: 2026/07/08
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/30 (approval no.: —; approval date: 2026/10/29); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 4
NMPA · Table row 4 ↗ View source ↗ -
2026/10/30No longer listed under review
Yu Song Yuan Pharma Co., Ltd. romanized
CYHS2502282
Fact date: 2026/10/30 · Site observation date: 2026/10/30
Accepted: 2025/06/26
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/10/30No longer listed under review
Chongqing Ke Rui Nan Hai Pharmaceutical Co., Ltd. romanized; Yu Song Yuan Pharma Co., Ltd. romanized
CYHB2601414
Fact date: 2026/10/30 · Site observation date: 2026/10/30
Accepted: 2026/07/24
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/10/29Supplement delivery
Hunan Wei Te Pharmaceutical Co., Ltd. romanized
CYHB2601317
Fact date: 2026/10/29 · Publication date: 2026/10/30 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 7 ↗ -
2026/10/29Supplement delivery
Hunan Wei Te Pharmaceutical Co., Ltd. romanized
CYHB2601316
Fact date: 2026/10/29 · Publication date: 2026/10/30 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 6 ↗ -
2026/10/29Supplement delivery
Jiangsu Vanguard Pharmaceutical Co., Ltd.
CYHB2601287
Fact date: 2026/10/29 · Publication date: 2026/10/30 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 5 ↗ -
2026/10/29Supplement delivery
Jiangsu Vanguard Pharmaceutical Co., Ltd.
CYHB2601286
Fact date: 2026/10/29 · Publication date: 2026/10/30 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 4 ↗ -
2026/10/29No longer listed under review
Sichuan Mei Da Kang Pharma Co., Ltd. romanized
CYHS2502758
Fact date: 2026/10/29 · Site observation date: 2026/10/29
Accepted: 2025/07/31
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/10/29Accepted
TIANJIN LISHENG PHARMACEUTICAL CO., LTD
CYHB2601980
Fact date: 2026/10/29 · Site observation date: 2026/10/30
View source ↗ -
2026/10/28Notification delivery
Beijing Heng Sheng Pharma Co., Ltd. romanized
CYHS2504049
Fact date: 2026/10/28 (Publication date) · Publication date: 2026/10/28 · Site observation date: 2026/11/03
Notification delivered; the specific outcome remains to be checked.
View source · Table row 17 ↗ -
2026/10/26Marketing application approved
Sichuan Mei Da Kang Pharma Co., Ltd. romanized
CYHS2502759 · 国药准字H20266400
Fact date: 2026/10/26 · Publication date: 2026/10/27 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 55 ↗ -
2026/10/21Notification delivery
Shandong Lu Kang Pharmaceuticals Group Sai Te Co., Ltd. romanized
CYHS2501417
Fact date: 2026/10/21 (Publication date) · Publication date: 2026/10/21 · Site observation date: 2026/11/03
Notification delivered; the specific outcome remains to be checked.
View source · Table row 6 ↗ -
2026/10/21Notification delivery
Shandong Lu Kang Pharmaceuticals Group Sai Te Co., Ltd. romanized
CYHS2501416
Fact date: 2026/10/21 (Publication date) · Publication date: 2026/10/21 · Site observation date: 2026/11/03
Notification delivered; the specific outcome remains to be checked.
View source · Table row 5 ↗ -
2026/10/21Notification delivery
Hainan Sai Li Ke Pharma Co., Ltd. romanized
CYHS2501178
Fact date: 2026/10/21 (Publication date) · Publication date: 2026/10/21 · Site observation date: 2026/11/03
Notification delivered; the specific outcome remains to be checked.
View source · Table row 4 ↗ -
2026/10/13Accepted
Beijing Kang Li Sheng Pharmaceuticals Technology Kai Fa Co., Ltd. romanized; Shandong Wei Zhi Bai Ke Pharma Co., Ltd. romanized
CYHS2602518
Fact date: 2026/10/13 · Site observation date: 2026/10/21
View source ↗ -
2026/10/13Accepted
Beijing Kang Li Sheng Pharmaceuticals Technology Kai Fa Co., Ltd. romanized; Shandong Wei Zhi Bai Ke Pharma Co., Ltd. romanized
CYHS2602517
Fact date: 2026/10/13 · Site observation date: 2026/10/21
View source ↗ -
2026/10/12Accepted
Shenyang Ao Ji Na Pharma Co., Ltd. romanized
CYHB2601870
Fact date: 2026/10/12 · Site observation date: 2026/10/21
View source ↗ -
2026/10/10Accepted
Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized
CYHS2602484
Fact date: 2026/10/10 · Site observation date: 2026/10/21
View source ↗ -
2026/10/10Accepted
Zhengzhou Tai Feng Pharmaceutical Co., Ltd. romanized
CYHS2602483
Fact date: 2026/10/10 · Site observation date: 2026/10/21
View source ↗ -
2026/09/29Accepted
Suzhou Zhong Hua Medicines Gong Ye Co., Ltd. romanized
CYHB2601822
Fact date: 2026/09/29 · Site observation date: 2026/10/21
View source ↗ -
2026/09/20Accepted
Yan Tai Lu Yin Pharma Co., Ltd. romanized
CYHS2602352
Fact date: 2026/09/20 · Site observation date: 2026/10/21
View source ↗ -
2026/09/20Accepted
Yan Tai Lu Yin Pharma Co., Ltd. romanized
CYHS2602351
Fact date: 2026/09/20 · Site observation date: 2026/10/21
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Sacubitril Valsartan Sodium Tablets
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy